Final efficacy results of neratinib in HER2-positive hormone receptor-positive early-stage breast cancer from the phase III ExteNET trial
Chan, Arlene, Moy, Beverly, Mansi, Janine, Ejlertsen, Bent, Holmes, Frankie Ann, Chia, Stephen, Iwata, Hiroji, Gnant, Michael, Loibl, Sibylle, Barrios, Carlos H., Somali, Isil, Smichkoska, Snezhana, MJournal:
Clinical Breast Cancer
DOI:
10.1016/j.clbc.2020.09.014
Date:
October, 2020
File:
PDF, 1.80 MB
2020
File converter
More search results
More benefits 
